The primary tumor resection in patients with distant metastatic laryngeal carcinoma

被引:2
作者
Lin, Zhongyang [1 ]
Lin, Hanqing [2 ]
Chen, Xihang [1 ]
Xu, Yuanteng [1 ]
Wu, Xiaobo [1 ]
Ke, Xiaoying [1 ]
Lin, Chang [1 ]
机构
[1] Fujian Med Univ, Dept Otolaryngol, Affiliated Hosp 1, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[2] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otolaryngol, 83 Fenyang Rd, Shanghai 200031, Peoples R China
关键词
Laryngeal carcinoma; Distant metastatic; Propensity score matching; Primary tumor resection; SEER database; SQUAMOUS-CELL-CARCINOMA; HEAD; CANCER; SURVIVAL; CHEMOTHERAPY; NIVOLUMAB; RECURRENT;
D O I
10.1007/s00405-020-05987-9
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background The role of primary tumor resection in patients with distant metastatic laryngeal carcinoma (DMLC) has not been clarified completely. Thus, we used propensity score matching (PSM) and survival analysis to address this issue. Methods The PSM was utilized to avoid selection bias and disproportionate distributions of the confounding factors. Kaplan-Meier estimates and Cox proportional hazard analysis were utilized to evaluate overall survival (OS) and cancer-specific survival (CSS). Results From the Surveillance, Epidemiology, and End Results Program database, a cohort of 480 patients with DMLC were included. After PSM, the OS and CSS for patients who underwent resection were significantly longer than those without resection (median OS: 19 months vs. 8 months, P < 0.001; median CSS: 19 months vs. 9 months, P = 0.002). Tumor resection significantly prolonged survival of DMLC patients with appropriate demographic and clinical characteristics. In the multivariate analysis, age at diagnosis, race, pathologic subtype, and marital status were found significantly affecting both OS and CSS of patients who underwent surgical resection. Predictive nomograms were developed to help distinguish patients with early mortality potential after surgical resection. Conclusions This study is the first one using PSM to assess the role played by surgical resection in DMLC and evaluate the prognostic factor of resected patients. Premised on well controlled postoperative complications, resection could significantly prolong OS and CSS of certain patients.
引用
收藏
页码:2859 / 2868
页数:10
相关论文
共 28 条
  • [1] [Anonymous], 2019, Clinical Practice Guidelines: Breast Cancer
  • [2] Head and neck cancer
    Argiris, Athanassios
    Karamouzis, Michalis V.
    Raben, David
    Ferris, Robert L.
    [J]. LANCET, 2008, 371 (9625) : 1695 - 1709
  • [3] Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial
    Bourhis, Jean
    Sire, Christian
    Graff, Pierre
    Gregoire, Vincent
    Maingon, Philippe
    Calais, Gilles
    Gery, Bernard
    Martin, Laurent
    Alfonsi, Marc
    Desprez, Patrick
    Pignon, Thierry
    Bardet, Etienne
    Rives, Michel
    Geoffrois, Lionel
    Daly-Schveitzer, Nicolas
    Sen, Sok
    Tuchais, Claude
    Dupuis, Olivier
    Guerif, Stephane
    Lapeyre, Michel
    Favrel, Veronique
    Hamoir, Marc
    Lusinchi, Antoine
    Temam, Stephane
    Pinna, Antonella
    Tao, Yun Gan
    Blanchard, Pierre
    Auperin, Anne
    [J]. LANCET ONCOLOGY, 2012, 13 (02) : 145 - 153
  • [4] Does smoking influence survival in cancer patients through effects on respiratory and vascular disease?
    Clark, TG
    Murphy, MFG
    Hey, K
    Drury, M
    Cheng, KK
    Aveyard, P
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2006, 15 (01) : 87 - 90
  • [5] Forest plots and the interpretation of subgroups
    Cuzick, J
    [J]. LANCET, 2005, 365 (9467) : 1308 - 1308
  • [6] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1856 - 1867
  • [7] The Cancer Survival Query System: Making Survival Estimates From the Surveillance, Epidemiology, and End Results Program More Timely and Relevant for Recently Diagnosed Patients
    Feuer, Eric J.
    Lee, Minjung
    Mariotto, Angela B.
    Cronin, Kathy A.
    Scoppa, Steve
    Penson, David F.
    Hachey, Mark
    Cynkin, Laurie
    Carter, Ginger A.
    Campbell, David
    Percy-Laurry, Antoinette
    Zou, Zhaohui
    Schrag, Deborah
    Hankey, Benjamin F.
    [J]. CANCER, 2012, 118 (22) : 5652 - 5662
  • [8] Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis
    Flanigan, RC
    Mickisch, G
    Sylvester, R
    Tangen, C
    Van Poppel, H
    Crawford, ED
    [J]. JOURNAL OF UROLOGY, 2004, 171 (03) : 1071 - 1076
  • [9] Basaloid squamous cell carcinoma of the head and neck: Location means everything
    Fritsch, Valerie A.
    Lentsch, Eric J.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (06) : 616 - 622
  • [10] A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Grover, Surbhi
    Mitra, Nandita
    Wan, Fei
    Lukens, John N.
    Sharma, Sonam
    Bauman, Jessica
    Masroor, Farzad
    Cohen, Roger B.
    Desai, Arati
    Algazy, Kenneth
    Alonso-Basanta, Michelle
    Ahn, Peter
    Teo, Boon-Keng Kevin
    Chalian, Ara A.
    Weinstein, Gregory S.
    O'Malley, Bert W., Jr.
    Lin, Alexander
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (05): : 522 - 527